Home
All Journals
Expert Opinion on Emerging Drugs
List of Issues
Volume 28, Issue 2

Expert Opinion on Emerging Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Emerging Drugs, Volume 28, Issue 2 (2023)

Browse this journal

Latest articles
Current issue
List of issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Emerging Drugs, Volume 28, Issue 2 (2023)

See all volumes and issues

Vol 29, 2024 Volume 28, 2023 Vol 27, 2022 Vol 26, 2021 Vol 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Mini review

Review

Emerging drugs for hepatitis D

Onur Keskin & Cihan Yurdaydin

Pages: 55-66

Published online: 27 Apr 2023

AbstractforEmerging drugs for hepatitis D | Full Text | References | PDF (1.1 MB) | EPUB

133 Views
0 CrossRef citations
0Altmetric

Review

Emerging drugs in the treatment of chronic cough

Danica Brister, Mustafaa Wahab, Moaaz Rashad, Nermin Diab, Martin Kolb & Imran Satia

Pages: 67-77

Published online: 24 Apr 2023

AbstractforEmerging drugs in the treatment of chronic cough | Full Text | References | PDF (816.8 KB) | EPUB

540 Views
0 CrossRef citations
0Altmetric

Review

Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials

Marcello Silvestro, Ilaria Orologio, Mattia Siciliano, Francesca Trojsi, Alessandro Tessitore, Gioacchino Tedeschi & Antonio Russo

Pages: 79-96

Published online: 28 Apr 2023

AbstractforEmerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials | Full Text | References | PDF (3.5 MB) | EPUB

525 Views
0 CrossRef citations
0Altmetric

Review

New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma

Flavia Bonini, Luana Guimarães de Sousa & Renata Ferrarotto

Pages: 97-106

Published online: 23 Jun 2023

218 Views
0 CrossRef citations
0Altmetric

Review Article

Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials

Robert I. Fox, Carla M. Fox & Sara S. McCoy

Pages: 107-120

Published online: 08 May 2023

AbstractforEmerging treatment for Sjögren’s disease: a review of recent phase II and III trials | Full Text | References | PDF (343.7 KB) | EPUB

467 Views
0 CrossRef citations
0Altmetric

Review Article

Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?

Francesca Casaluce & Cesare Gridelli

Pages: 121-127

Published online: 09 May 2023

AbstractforCombined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly? | Full Text | References | PDF (240.1 KB) | EPUB

222 Views
0 CrossRef citations
0Altmetric

Review Article

Emerging peptide therapeutics for the treatment of ovarian cancer

Ana C. Veneziani, Eduardo Gonzalez-Ochoa & Amit M. Oza

Pages: 129-144

Published online: 07 Jun 2023

AbstractforEmerging peptide therapeutics for the treatment of ovarian cancer | Full Text | References | PDF (3 MB) | EPUB

2291 Views
0 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Emerging drugs for the treatment of short bowel syndrome

Tristan Frau et al.

Review Article | Published online: 23 May 2024

Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder

Elliot Hampsey et al.

Review Article | Published online: 8 May 2024

Open Access

Emerging immunotherapies in the Hodgkin lymphoma armamentarium

Michael A. Spinner et al.

Review Article | Published online: 6 May 2024

Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials

Ogechi Obed et al.

Review Article | Published online: 28 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Emerging Drugs (Vol.28, Iss.2, 2023)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?